Jill E. Slansky
- Immunology top 0.5%
- Oncology top 1%
- Molecular Biology top 5%
- Genetics top 5%
- Epidemiology top 5%
- Co-authors
- Peggy FarnhamDavid SourdiveAllan ZajacJoseph D. MillerRafi AhmedM. SureshJohn D. AltmanKaja Murali‐Krishna
- Topics
- Immunotherapy and Immune Responses (40 papers)Immune Cell Function and Interaction (25 papers)CAR-T cell therapy research (19 papers)
- Cited by
- ImmunologyOncologyVirology
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Biological Chemistry
- Partner nations
- United StatesFranceChina
In The Last Decade
Jill E. Slansky
72 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Immunology 4.0k
- Oncology 2.5k
- Molecular Biology 2.0k
- Genetics 610
- Epidemiology 498
Countries citing papers authored by Jill E. Slansky
This map shows the geographic impact of Jill E. Slansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill E. Slansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill E. Slansky more than expected).
Fields of papers citing papers by Jill E. Slansky
This network shows the impact of papers produced by Jill E. Slansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill E. Slansky. The network helps show where Jill E. Slansky may publish in the future.
Co-authorship network of co-authors of Jill E. Slansky
This figure shows the co-authorship network connecting the top 25 collaborators of Jill E. Slansky. A scholar is included among the top collaborators of Jill E. Slansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill E. Slansky. Jill E. Slansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 40 | |
| 4 | 6 | |
| 5 | 36 | |
| 6 | 127 | |
| 7 | 103 | |
| 8 | 34 | |
| 9 | 1 | |
| 10 | 125 | |
| 11 | 23 | |
| 12 | 25 | |
| 13 | 31 | |
| 14 | 29 | |
| 15 | 48 | |
| 16 | 32 | |
| 17 | 78 | |
| 18 | 50 | |
| 19 | Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infectionbreakdown → | 1716 |
| 20 | 55 |
About Jill E. Slansky
Jill E. Slansky is a scholar working on Immunology, Oncology and Biotechnology, having authored 79 papers that have together received 6.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (40 papers), Immune Cell Function and Interaction (25 papers) and CAR-T cell therapy research (19 papers). The work is most often cited by research in Immunology (4.0k citations), Oncology (2.5k citations) and Virology (226 citations). Jill E. Slansky has collaborated with scholars based in United States, France and China. Frequent co-authors include Peggy Farnham, David Sourdive, Allan Zajac, Joseph D. Miller, Rafi Ahmed, M. Suresh, John D. Altman, Kaja Murali‐Krishna, Drew M. Pardoll and Alexis L. Franks. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.